These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Early detection of bacteremia pathogens with rapid molecular diagnostic tests and evaluation of effect on intensive care patient management.
    Author: Tatli-Kis T, Yildirim S, Bicmen C, Kirakli C.
    Journal: Diagn Microbiol Infect Dis; 2024 Sep; 110(1):116424. PubMed ID: 38996775.
    Abstract:
    UNLABELLED: İNTRODUCTION: The BioFire FilmArray Blood Culture Identification panel (BCID2), a rapid molecular blood culture identification test based on multiplex nested polymerase chain reaction. The aim of this study was to evaluate clinical outcomes between the period before (pre-BCID2 group) and after (post-BCID2 group) the introduction of the BCID2 panel into our routine practice. METHODS: The primary endpoint was time to optimal antibiotherapy, and the secondary endpoints were duration of hospital and intensive care unit stay, 7-day, 14-day and 28-day mortality rates after bacteremia. RESULTS: The median time from empirical antibiotherapy to optimal antimicrobial therapy was 4560 (IQR;3060-7140) minutes in the pre-BCID2 group and 1715 (IQR;1362- 2776.25) minutes (in the post-BCID2 group (p<0.05). CONCLUSION: Adding the BCID2 panel may improve antibiotic management in critically ill bacteremia patients.
    [Abstract] [Full Text] [Related] [New Search]